Novavax Stock Rockets over 200% as It Signs COVID-19 License Deal with Sanofi, Removes Doubt About Business Viability
(Reuters) - Novavax on Friday erased doubts about its ability to remain in business and struck a licensing deal worth up to $1.2 billion with $Sanofi(GCVRZ)$ for COVID-19 vaccines in exchange for a st